Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends and Associated Factors of Malnutrition Among Adolescents With Diarrhoea in Bangladesh: A Retrospective Cross-Sectional Surveillance Study Using Adaptive LASSO.

Health science reports·2026
Same author

Development and validation of a dementia risk prediction model for low- and middle-income countries: the 10/66 study.

American journal of epidemiology·2026
Same author

Barriers to and solutions for implementing nutrition-related health programmes for Rohingya refugees in Cox's Bazar.

International health·2026
Same author

Integration of poliovirus and enteropathogen sewage surveillance in Dhaka Bangladesh: a longitudinal surveillance study, June 2019-June 2020.

The Lancet. Microbe·2026
Same author

<i>Vibrio cholerae</i> O1 classical and El Tor toxin-coregulated pilus subunit A (TcpA) epitopes that induce biotype-specific and cross-protective antibodies against bacterial adherence.

Applied and environmental microbiology·2026
Same author

Serological responses to killed oral cholera vaccine (OCV) when given 4 years after initial receipt of OCV in Cameroon: A randomized controlled trial.

PLOS global public health·2026

Related Experiment Video

Updated: Jun 7, 2026

Epithelial Cell Infection Analyses with Shigella
04:56

Epithelial Cell Infection Analyses with Shigella

Published on: February 9, 2024

Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia.

Pradip Bardhan1, A S G Faruque, Aliya Naheed

  • 1International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.

Emerging Infectious Diseases
|October 30, 2010
PubMed
Summary

Shigellosis deaths in Asia have decreased by 98% since the late 1990s, with significantly lower case-fatality rates. This decline occurred without specific Shigella interventions, suggesting broader public health measures may be responsible.

More Related Videos

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

Related Experiment Videos

Last Updated: Jun 7, 2026

Epithelial Cell Infection Analyses with Shigella
04:56

Epithelial Cell Infection Analyses with Shigella

Published on: February 9, 2024

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

Area of Science:

  • Infectious Diseases
  • Public Health
  • Epidemiology

Background:

  • Previous literature (1966-1997) estimated ~1.1 million annual shigellosis deaths globally.
  • Asia accounted for a significant portion of these deaths, with ~880,000 fatalities.

Purpose of the Study:

  • To assess current annual shigellosis incidence and mortality in Asia.
  • To compare recent estimates with historical data and identify trends in case-fatality rates.

Main Methods:

  • A comprehensive review of scientific literature from 1990-2009.
  • Analysis of global and regional data on shigellosis cases and deaths.

Main Results:

  • An estimated 125 million annual shigellosis cases in Asia (1990-2009).
  • Approximately 14,000 annual shigellosis deaths in Asia, a 98% reduction compared to earlier estimates.
  • Reduced mortality is attributed to lower case-fatality rates, not fewer infections.

Conclusions:

  • Shigellosis-related mortality in Asia has dramatically decreased.
  • Nonspecific public health interventions like measles vaccination, vitamin A supplementation, and improved nutrition are potential contributors to this decline.
  • Further research is needed to confirm the impact of these nonspecific interventions on shigellosis outcomes.